References
- Ashihara Y., Kono T., Yamazaki S., Inada Y. Modification of E. coil l-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum. Biochem. Biophys. Res. Commun. 1978; 83: 385–391
- Barrowcliffe M. P., Zanelli G. D., Ellison D., Jones J. G. Clearance of charged and uncharged dextran from normal and injured lungs. J. Appl. Physiol. 1990; 68: 341–347
- Beauchamp C. O., Gonias S. L., Menapace D. P., Pizzo S. V. A new procedure for the synthesis of polyethylene glycol–protein adducts; effects on function, receptor recognition, and clearance of superoxide dimutase, lactoferrin, and α2-macroglobulin. Anal. Biochem. 1983; 131: 25–33
- Bendich A., Abuchowski A., Davis F. F. Immunological effects of native and polyethylene glycol-modified asparaginases from Vibrio succinogenes and Escherichia coli in normal and tumor-bearing mice. Clin. Exp. Immunol. 1982; 48: 273–278
- Greenwood F. C., Hunter W. M., Gloven T. C. The preparation of 125I-labeled human growth hormone of high specific radioactivity. Biochem. J. 1963; 89: 114–123
- Hashida M., Atsumi R., Nishida K., Nakane S., Takakura Y., Sezaki H. Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran. J. Pharmacobiodyn. 1990; 13: 441–447
- Hershfield M. S., Buckley R. H., Greenburg M. L., Melton A. L., Schiff R., Hatem C., Kurtzberg J., Marken M. L., Kobayashi R. H., Kobayashi A. L., Abuchowski A. N. Treatment of adenosine deaminase deficiency with polyethylene glycol–modified adenosine deaminase. N. Engl. J. Med. 1987; 316: 589–596
- Ilium L., Eright J., Davis S. S. Targeting of microspheres to sites of inflammation. Int. J. Pharm. 1989; 52: 221–224
- Kamata R., Yamamoto T., Matsumoto K., Maeda H. A serratial protease causes vascular permeability reaction by activation of the Hageman factor–dependent pathway in guinea pigs. Infect. Immun. 1985; 48: 747–753
- Kaneo Y., Tanaka T., Fujihara Y., Mori H., Iguchi S. Delivery of glutathione, as a dextran conjugate, into the liver. Int. J. Pharm. 1988; 44: 265–267
- Love W. G., Farr S. J., Kellaway I. W., Williams B. D. Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. Ann. Rheum. Dis. 1990; 49: 611–614
- Melton R. G., Wiblin C. N., Foster R. L., Sherwood R. F. Covalent linkage of carboxypeptidase G2 to soluble dextran—II. In vivo distribution and fate of conjugate. Biochem. Pharmacol. 1987; 36: 105–112
- Mizushima Y. Lipid microspheres as novel drug carriers. Drugs Exp. Clin. Res. 1985; 11: 595–600
- Mizushima Y. pplication of lipid microspheres for targeting therapy. J. Bioact. Comp. Polym. 1988a; 3
- Mizushima Y., Wada Y., Etoh Y., Watanabe K. nti-inflammatory effects of indomethacin ester incorporated in a lipid microsphere. J. Pharm. Pharmacol. 1983a; 35: 398–399
- Nakajima N., Ikada Y. Fusogenic activity of various water-soluble polymers. J. Biomater. Sci. Polym. Ed. 1995; 6: 751–758
- Przybyski M., Fell E., Ringsdorf H. Syntheses and characterization of polymeric derivatives of the antitumor agent. Makromol. Chem. 1978; 179: 1733–1791
- Sunamoto J., Iwamoto K. Protein-coated and polysaccharide-coated liposomes as drug carriers. CRC Crit. Rev. Ther. Drug Carrier Syst. 1986; 2: 117–136
- Takakura Y., Takagi A., Hashida M., Sezaki H. Disposition and tumor localization of mitomycin C–dextran conjugates in mice. Pharm. Res. 1987; 4: 223–230
- Takakura Y., Atumi R., Hashida M., Sezaki H. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 1990; 7: 339–346
- Yamaoka T., Tabata Y., Ikada Y. Body distribution profile of polysaccharides after intravenous administration. Drug Deliv. 1993; 1: 75–82
- Yamaoka T., Tabata Y., Ikada Y. Distribution and tissue uptake of polyethylene glycol with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 1994; 83: 601–606
- Yamaoka T., Kuroda M., Tabata Y., Ikada Y. Body distribution of dextran derivatives with electric charges after intravenous administration. Int. J. Pharm. 1995a; 113: 149–157
- Yamaoka T., Tabata Y., Ikada Y. Comparison of body distribution of poly(vinyl alchol) with other water-soluble polymers after intravenous administration. J. Pharm. Pharmacol. 1995b; 47: 470–486
- Yoshimoto T., Nishimura H., Saito Y., Sakurai K., Kamisaki Y., Wada H., Sako M., Tsujino G., Inada Y. Characterization of polyethylene glycol-modified l-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. (Gann) 1986; 77: 1264–1270